Jump to content

IQVIA

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 209.133.65.222 (talk) at 19:27, 18 May 2016. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Quintiles Transnational, Inc
Company typePublic
NYSE: Q
IndustryContract Research Organization
Pharmaceutical Service Consulting
Founded1982
HeadquartersDurham, North Carolina, USA
Key people
Dennis Gillings, Founder
Tom Pike CEO
Kevin Gordon COO
ProductsSupport services for pharmaceutical, biotech and medical companies and individuals
RevenueIncreaseUS$ Approximately $4.2 billion in Service Revenue (2014)[citation needed]
Number of employees
~ 35,000 (2015)
Websitehttp://www.quintiles.com/

Quintiles Transnational, INC (NYSE: Q), is a Fortune 500 company and the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 35,000 employees conducting business in approximately 100 countries.

Quintiles is the world’s largest contract research organization[1] as ranked by reported service revenues, and is focused primarily on Phase II-IV clinical trials and associated laboratory and analytical services. The division of Quintiles Integrated Healthcare Services is an outsourcing partner for pharmaceutical companies to support sales and healthcare business services, such as outcome research and marketing.

History

In 1982, Dennis Gillings founded and incorporated Quintiles Transnational in North Carolina.[2]

Quintiles Transnational established Quintiles Pacific Inc. and Quintiles Ireland Ltd. in 1990,[3] and in 1991 Quintiles GmbH was established in Germany and Quintiles Laboratories Ltd. was established in Atlanta, Georgia.[4]

In September 1996, Quintiles purchased Innovex Ltd. of Britain for $747.5 million in stock.[5]

Quintiles went public in 1997 and completed a successful secondary stock offering.[6]

References

  1. ^ "Inside Quintiles: The World's Largest CRO". Outsourcing-Pharma.com.
  2. ^ Matthew Herper (November 22, 2010). "Money, Math and Medicine". Forbes Magazine. Retrieved July 21, 2011.
  3. ^ "Quintiles Pacific, Inc.: Private Company Information - Businessweek".
  4. ^ "Quintiles Laboratories Limited: Private Company Information - Businessweek".
  5. ^ "Quintiles Transnational Corp". Encyclopedia.com. 2005. {{cite web}}: Cite uses deprecated parameter |authors= (help)
  6. ^ Olivia Oran (9 May 2013). "Quintiles IPO raises more-than-planned $947 million as stocks rally". Reuters.
Retrieved from "https://en.wikipedia.org/w/index.php?title=IQVIA&oldid=720921664"